Adjuvant therapy in type 1 diabetes mellitus

Endokrynol Pol. 2021;72(1):87-88. doi: 10.5603/EP.a2021.0003. Epub 2021 Feb 23.

Authors

Edyta Cichocka¹, Anna Maj-Podsiadło, Janusz Gumprecht²

Affiliations

¹ Department of Internal Medicine, Diabetology, and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland. ecichocka@sum.edu.pl.
² Department of Internal Medicine, Diabetology, and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland.

PMID: 33619718
DOI: 10.5603/EP.a2021.0003

Abstract

Not required for Clinical Vignette.

Keywords: adjuvant therapy; type 1 diabetes mellitus.

Publication types

Case Reports

MeSH terms

Adult
Diabetes Mellitus, Type 1 / drug therapy*
Diabetes Mellitus, Type 1 / metabolism
Diabetic Nephropathies / prevention & control
Female
Glycated Hemoglobin / analysis
Heart Failure / prevention & control
Humans
Hypoglycemic Agents / therapeutic use*
Male
Sodium-Glucose Transporter 2 / metabolism*
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use*

Substances

Glycated Hemoglobin A
Hypoglycemic Agents
Sodium-Glucose Transporter 2
Sodium-Glucose Transporter 2 Inhibitors